Skip to main content
Clinical Trials/PACTR202303539794048
PACTR202303539794048
Other
Phase 1

A randomized double-blinded clinical trial to investigate the role of ultrasound-guided transversus abdominis plane block after a radical hysterectomy of cervical cancer

Bahir Dar University0 sites60 target enrollmentFebruary 23, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Cancer
Sponsor
Bahir Dar University
Enrollment
60
Status
Other
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 23, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • All adults aged greater than 18 years old with the following criteria will be considered.
  • Patients with the classification of ASA physical status II and III
  • Patients who can tolerate a general anesthetic
  • Patients undergoing cervical cancer surgery (radical hysterectomy) under general anesthesia,
  • Patients who can provide informed consent for the surgery
  • 20 ml of 0\.25 % bupivacaine will be given for cases (TAP block) at the end of the surgery
  • Patients' weights are between 40\-80 kg.
  • Patients who can provide informed consent for the surgery

Exclusion Criteria

  • Patients who have bleeding disorders
  • Patients who are GCS \<15
  • Communication failure
  • Patients who have an allergy to local anesthetics
  • Patients who have multiple site surgery (outside of abdomen)
  • Patients who have underlying cardiovascular diseases
  • Patients with chronic pain and opioid use (using oral morphine greater than 100 mg daily).

Outcomes

Primary Outcomes

Not specified

Similar Trials